Loading
DG
Daan Gene Co., Ltd.: what insiders have been doing
Insider filings for Daan Gene Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 20 December 2021. This page will fill in as new trades are disclosed. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: People's Republic of China · Founded: 1988
Source: Wikidata (CC0).
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3M
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,642 of 24,158 companies
26.5
score / 100
Value31
Quality22
FCF yld1.0%
Earn yld-9.1%
EV/EBITDA·
ROE-9.4%
Gross mgn32%
Net mgn-98%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥5.83
Analyst consensus
Income statement
RevenueCN¥757.7M
Gross profitCN¥245.5M32% margin
EBITDA-CN¥453.1M-60% margin
Net income-CN¥744.4M-91.4% margin
Valuation
P/Book1.2x
Beta0.45
Balance sheet & cash
Market capCN¥8.2B
Total debtCN¥114.7M
Free Cash FlowCN¥80.5M
Debt / Equity1%
Profitability & ownership
ROE-9.4%
ROA-2.0%
% insiders35.4%
% institutions1.5%
Last declaration on 20 December 2021
About Daan Gene Co., Ltd.
达安基因 is a company focused on the research and development of molecular diagnostic products. It specializes in genetic testing and public health solutions.
